SARS-COV-2 variant COVID-19 vaccination rate (%) Control(s) Intervention M N Design Place First author, year
SOC Infliximab 17 24 Observational Germany Stallmach, 2020
Control; IVIg; infliximab + IVIg Infliximab 68 104 Observational Iran Farrokhpour, 2021
Placebo Infliximab 40 69 RCT UK Fisher, 2021
Placebo Infliximab 637 1061 RCT USA O’Halloran, 2023
SOC Infliximab 50 190 observational Italy Taleng, 2021